Table 3.
Responses of CD8+ T hybridomas generated by vaccination with the MBP-specific CD4+Vβ8+ syngeneic T cell clone 1AE10
Response
|
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stimulators
|
T cell hybridoma 21-5A9
|
T cell hybridoma 176-5F7
|
||||||||||||
Name | Specificity | Vβ | H-2 | Qa-1 | Exp. 1 | Exp. 2 | Exp. 3 | Exp. 4 | Exp. 5 | Exp. 1 | Exp. 2 | Exp. 3 | Exp. 4 | Exp. 5 |
1AE10 | MBP | 8.3 | u | a | 2+ | 0.461 | 0.846 | 0.324 | 0.309 | 2+ | 0.415 | 0.513 | 0.178 | 0.248 |
1AC3 | MBP | 8.2 | u | a | 2+ | 0.377 | 0.580 | 0.120 | 0.264 | ± | 0.060 | 0.054 | 0.000 | 0.037 |
3AC3 | MBP | 8.3 | u | a | 2+ | NT | 0.242 | 0.040 | 0.293 | 2+ | NT | 0.209 | 0.043 | 0.223 |
SEB-Vβ8 | SEB | 8.2 | u | a | 1+ | 0.508 | 0.731 | 0.416 | 0.208 | 2+ | 0.514 | 0.637 | 0.386 | 0.222 |
3AB3 | MBP | 6 | u | a | ± | 0.164 | 0.127 | 0.055 | NT | 0 | 0.062 | 0.041 | 0.027 | NT |
3AF9 | MBP | 6 | u | a | 0 | 0.080 | 0.071 | 0.039 | NT | 0 | 0.183 | 0.117 | 0.068 | NT |
3AG2 | MBP | 6 | u | a | 0 | 0.131 | 0.054 | 0.043 | NT | 2+ | 0.478 | 0.534 | 0.314 | NT |
3BB8 | MBP | 6 | u | a | 0 | 0.172 | 0.101 | 0.082 | NT | 0 | 0.212 | 0.178 | 0.098 | NT |
LBRM | — | 8.2 | k | a | 2+ | 0.844 | 1.434 | 0.926 | 0.611 | 2+ | 0.923 | 1.285 | 0.846 | 0.611 |
J1-9f | — | 8.2 | HLA | b | 0 | NT | 0.114 | 0.096 | 0.028 | 0 | NT | 0.019 | 0.018 | 0.007 |
4G4-6B5 | — | 8.2 | k | b | 0 | NT | 0.106 | 0.079 | 0.017 | 0 | NT | 0.086 | 0.082 | 0.017 |
PI | — | — | — | — | 3+ | 1.019 | 1.497 | 0.972 | 0.739 | 3+ | 0.782 | 1.268 | 0.484 | 0.327 |
The results for experiment 1 represent the visual estimates of the responses derived by counting the numbers of blue cells in each well containing 5 × 104 cells after fixation and incubation of the hybridomas with X-Gal (0 = <20; ± = <100; 1+ = 100–1,000; 2+ >1,000; and 3+ = virtually all). The results for experiments 2–6 represent the means minus the background (CD8 cells alone) of a colorimetric assay of β-galactosidase activity. NT, not tested. PI indicates the culture of the hybridomas for 4 hr with 20 ng/ml phorbol 12,13-dibutyrate and 0.4 μM ionomycin.